AzTrials
AzTrials

Cerebrovascular AccidentsNCT02544672

Function Benefits of a Myoelectric Elbow-Wrist-Hand Orthosis

A study testing Myoelectric Elbow-Wrist-Hand orthosis in people with Cerebrovascular Accidents, run by Myomo at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this study is to evaluate the functional benefits of a myoelectric Elbow-Wrist-Hand orthosis for persons with upper limb paralysis caused by a cerebrovascular accident (CVA). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cerebrovascular Accidents
What is being tested?
Myoelectric Elbow-Wrist-Hand orthosis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
Jul 2015to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults over 18 years.
  • Upper limb impairment caused by any stroke (CVA)
  • Minimum of trace MMT (1/5) in Biceps and/or Triceps
  • Full Passive range of motion in elbow, forearm, wrist, and hand
  • Active shoulder flexion of at least 30 degrees of shoulder abduction of at least 20 degrees
  • Score of at least 20 on the Mini Mental Status Examination.
  • Ability to read and comprehend the English language.
  • Ability to generate consistent, detectable EMG signal from the upper arm and forearm sensor sites with wrist in neutral or flexed positions.

Who cannot join

  • Fixed upper limb contractures on affected side.
  • Subjects with severe spasticity or tone (defined as 3 or more on the Modified Ashworth Scale).
  • Inability to follow three step directions.
  • Severe shoulder subluxation, pain or shoulder dislocation.
  • Passive shoulder range of motion less than 45 degrees in flexion and abduction.
  • Pain or hypersensitivity in the arm(s)

Trial locations and contacts

1 site in 1 country.

Jonathan Naft, CPO, LPO contact

440-285-5785

jnaft@greop.com

United States1 site, 1 recruiting
  • GRE Chardon

    Chardon, Ohio, 44024

    Jonathan Naft, CPO, LPO, 440-285-5785, jnaft@greop.com

    Recruiting

Other trials in United States

About this study

The objective of this study is to evaluate the functional benefits of a myoelectric Elbow-Wrist-Hand orthosis for persons with upper limb paralysis caused by a cerebrovascular accident (CVA).

Read the detailed description

The objective of this study is to evaluate the functional gains provided by a myoelectric Elbow-Wrist-Hand orthosis for CVA patients with hemiparesis. The subjects will be fit with the device, provided general training in the operation of the EMG-controlled technology, and then guided through a series of standard clinical outcome measures used routinely as part of stroke rehabilitation medicine. The outcome measures employed in this study include the Fugl-Meyer assessment, the Box and Blocks test, and a battery of common functional tasks and activities. These outcome measures will allow the researchers to approximate the changes in the subjects' ability to successfully perform functional tasks with and without the MyoPro device.

Being tested
Myoelectric Elbow-Wrist-Hand orthosis
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Myoelectric Elbow-Wrist-Hand orthosisDevice

    Also called MyoPro®

    An arm orthosis that uses myoelectric signals to control the level of mechanical assistance provided to a user's elbow and hand in order to overcome upper limb weakness or paralysis and achieve functional tasks.

Study groups in NCT02544672
Study groupRoleWhat they receive
Myoelectric Elbow-Wrist-Hand OrthosisExperimentalNot described
Receives: Device: Myoelectric Elbow-Wrist-Hand orthosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment Upper Extremity (FMA-UE)

    Assessment of sensorimotor function for the upper extremities (arms)

    http://www.rehabmeasures.org/lists/rehabmeasures/dispform.aspx?ID=908

    Measured: 2 hours

  2. Modified Ashworth Scale

    Measurement of muscle spasticity due to nervous system injury or disease

    http://www.rehabmeasures.org/Lists/RehabMeasures/PrintView.aspx?ID=902

    Measured: 2 hours

  3. Box and Blocks Test

    An assessment of unilateral gross manual dexterity, measured by the number 1 inch cubes an individual can move over a barrier in a 60 second time period.

    http://www.rehabmeasures.org/Lists/RehabMeasures/DispForm.aspx?ID=917

    Measured: 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2015 (estimated)
  2. Study startJul 2015
  3. Primary completionJul 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02544672
Sponsor's protocol ID
15-260
Status last verified
Sep 2015
First submitted
1 Sep 2015
Last updated
9 Sep 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Myoelectric Elbow-Wrist-Hand orthosis in people with Cerebrovascular Accidents, run by Myomo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jonathan Naft, CPO, LPO (440-285-5785, jnaft@greop.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment Upper Extremity (FMA-UE) (time frame: 2 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in